Prot #2003376607: NU JH17U01: Overcoming drug resistance in metastatic castration-resistant prostate cancer with novel combination of TGF-β receptor inhibitor LY2157299 and enzalutamide: a randomized multi-site phase II study

Project: Research project

Project Details

StatusActive
Effective start/end date9/1/1712/31/21

Funding

  • Johns Hopkins University (Prot #2003376607)